Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-019-03063-4.pdf
Reference27 articles.
1. Saluja R, Cheung P, Zukotynski K, Emmenegger U (2016) Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: from chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urol Oncol 34(5):225–232
2. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10
3. Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L et al (2018) Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group. Lancet Oncol 19(10):e534–e545
4. De Bruycker A, Lambert B, Claeys T, Delrue L, Mbah C, De Meerleer G et al (2017) Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy. BJU Int 120(6):815–821
5. Graziani T, Ceci F, Castellucci P, Polverari G, Lima GM, Lodi F et al (2016) (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series. Eur J Nucl Med Mol Imaging 43(11):1971–1979
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05);Practical Radiation Oncology;2024-09
2. Progress in Oligometastatic Prostate Cancer: Emerging Imaging Innovations and Therapeutic Approaches;Cancers;2024-01-24
3. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer;Clinical and Translational Oncology;2022-12-16
4. Oligometastatic Prostate Cancer: Current Status and Future Challenges;Journal of Nuclear Medicine;2022-11
5. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature;Actas Urológicas Españolas (English Edition);2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3